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418 THE CLINICAL ASSOCIATIONS OF KNEE CARTILAGE
DEFECTS IN AN OBESE POPULATION
A. Anandacoomarasamy1, I. Caterson2, G. Smith1, S. Leibman1,
B. Giuffre1, M. Fransen3, P. Sambrook1, L. March1. 1University
of Sydney, Northern Clinical School, IBJR, Royal North Shore
Hospital, Sydney, AUSTRALIA, 2Royal Prince Alfred Hospital, Sydney,
AUSTRALIA, 3George Institute, Sydney, AUSTRALIA
Purpose: To generate hypothesis regarding the associations of knee
cartilage defects in an obese population with and without OA.
Methods: Obese subjects (BMI> 30) were recruited from laparoscopic
adjustable gastric banding or exercise and diet weight loss programs.
ACR clinical criteria for OA knee were determined. MRI assessment
was conducted on a 3T machine (Magnetom Trio; Siemens, Erlangen,
Germany) at baseline. Cartilage defects were graded according to an
established protocol at medial tibial, medial femoral, lateral tibial, lateral
femoral and patellar sites (grade 0−4). Composite scores for medial
tibiofemoral, lateral tibiofemoral and whole compartments were obtained.
All subjects completed a general health and musculoskeletal (MSK)
questionnaire, WOMAC, SF-36, AQoL, Moorehead-Ardelt Quality of Life
Questionnaire II (developed in an obese population), and Multidimen-
sional Assessment of Fatigue. Physical assessment was conducted by a
single assessor. The MSK questionnaire assessed joint pain; activity level
at work, home and leisure; medication use; previous injury and previous
surgery. Physical assessment parameters included: range of knee and
hip motion; crepitus; alignment; quadriceps strength; waist, hip and knee
circumference. Correlations between cartilage defect scores and MSK
outcomes were obtained (Stata software). Regression analysis corrected
for age, gender, BMI and presence of knee OA.
Results: There were 111 subjects (78 women and 33 men) with mean
BMI 39.9±5.8 and mean age 51±12 years. Fifty-three (48%) subjects met
ACR criteria for knee OA. Knee cartilage defects were signiﬁcantly asso-
ciated with BMI (p< 0.03), presence of knee OA (p< 0.0001), knee pain
(p< 0.05), and duration of knee pain (p< 0.01) in the medial tibiofemoral
and whole compartments. There was statistically signiﬁcant association
with BMI and the lateral tibiofemoral compartment (p< 0.01). Signiﬁcant
associations were also seen with physical function, role physical, bodily
pain and general health on SF-36 (p< 0.05); pain, stiffness and func-
tion on WOMAC (p< 0.0001); and medication use and independence
subscale (p< 0.02) on AQoL for both the medial tibiofemoral and whole
compartments. The association between knee cartilage defects, and BMI
(p< 0.04) and knee OA (p< 0.0001) remained signiﬁcant in the medial
tibiofemoral and whole compartments on regression analysis. ICCs for
intra-observer reproducibility were >0.98 for all compartments.
Conclusions: Knee cartilage defects scores are signiﬁcantly associated
with BMI, knee OA, the presence and duration of knee pain. Cartilage
defects are also signiﬁcantly associated with a number of quality of life
measures indicating clinical signiﬁcance. They provide a time-efﬁcient
means of assessing articular cartilage which is reproducible. With the
rising prevalence of obesity, it is important to assess the natural history of
cartilage defects in the obese population, a group at risk for both incident
and prevalent OA.
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Purpose: A 2 year study to compare change in cartilage thickness in non
OA and OA subjects, also provides an opportunity to identify individuals
with signiﬁcant decrease in cartilage thickness, i.e., progressors. Exami-
nation of only progressors may lead to better understanding of the location
and magnitude of changes in cartilage thickness over during clinical trials.
The objective of this study was to identify subjects with signiﬁcant medial
cartilage thickness decrease over two years and assess the location and
magnitude of their decrease.
Methods: In the A9001140 study, 152 female subjects were imaged at
7 clinical centers using Siemens Magnetom Trio and GE Signa Excite
magnets. Double oblique coronal acquisitions were obtained at baseline
and 2 years, using water excitation spoiled gradient echo sequences
(1.0×0.31×0.31mm3 resolution). Segmentation of femoro-tibial cartilage
morphology was performed using proprietary software (Chondrometrics,
Germany). Change in medial cartilage thickness (ThCtAB.aMe) over
24 months was measured for the whole compartment (cMFTC, MFTC),
the femoral and tibial plates (cMF, MT), 3 subregions of the femoral plate
(ccMF, ecMF, icMF) and 5 subregions (central, exterior, interior, anterior
and posterior) of the tibial plate (cMT, eMT, iMT, aMT, pMT). Kellgren and
Lawrence grades (KL) were observed on standing anteroposterior (AP)
and Lyon Schuss (LS) radiographs of the knee.
The 77 subjects with KL=0 scores on both AP and LS radiographs
were viewed as an unambiguous healthy group and deﬁned as non
OA subjects. Of the remaining 75 subjects, 13 had KL=0 only on the
AP radiographs, 4 were KL=1, 30 were KL=2, and 28 were KL=3.
While some subjects had AP KL=0, for convenience this group was
deﬁned as the OA group. Progressors were deﬁned as subjects with a
larger decrease in a cartilage thickness measure than expected from
examination of non OA distribution. Normalized values (z-scores) were
generated for non OA and OA subjects by subtracting the mean and
standard deviation of the non OA subjects. Speciﬁcally, the normalized
values were translated to p values from the normal distribution and small
p values were taken as indication of progression. Multiple comparisons
adjustments were made using false discovery rate methods (a=0.1) for
non OA and OA groups separately. Normality plots were used to check
if annualized rates of change in cartilage thickness for the non OA group
were normally distributed. Summary statistics regarding frequency and
magnitude of progression in different KL Groups and knee regions were
computed.
Results: 28% of the OA group were progressors, compared to 2.6% of
the non OA group. Using AP radiograph KL scores, 20% of KL2s were
progressors compared to 46% of KL3s. Twelve of the 23 progressors
had signiﬁcant progression in a single subregion, while 4 had signiﬁcant
progression in 4 or more subregions. Approximately 10% of subjects had
signiﬁcant progression when observing compartments (cMFTC, MFTC),
while 5−8% had progression when observing medial plates (cMF, MT).
The subregion with highest observed frequency of progression was eMT
(65% of progressors) followed by ccMF (35%). Mean percent annualized
rate of change in progressors ranged from −0.6% (pMT) to −5.9% (eMT)
with 4 of the subregions having annual percent decrease in thickness
greater than 3%. Rate of change in non progressors ranged between
−0.3 to 0.7%.
Conclusions: Over 2 years many subjects do have a signiﬁcant decrease
in cartilage thickness, but the decrease tends to be localized (1 subre-
gion). Although two subregions, eMT and ccMF, are the most frequently
observed locations for decrease in cartilage thickness, all subregions,
except pMT, are observed to have important decreases in some subjects.
420 DUAL ENERGY X-RAY ABSORPTIOMETRY ANALYSYS
CONTRIBUTE TO PREDICT HIP OSTEOARTHRITIS
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Purpose: To determine if parameters obtained from dual energy X-ray
absorptiometry (DXA) contribute to predict progression of hip osteoarthri-
tis (OA) and to test if the differerence between affected (OA) hip and
contralateral hip adds to this prediction.
Methods: The study group involves the “Glucosamine sulphate on os-
teoarthrtis long term” (GOAL) cohort from which we took 189 patients
that met the American College of Rheumatology clinical criteria for hip
osteoarthritis ands were included after their ﬁrst visit to the Phycisian.
DXA images, X-rays and pain and function scores (WOMAC) were
obtained from all patients at inclusion and after 2 years follow-up.
Software was developed for DXA analysis at different regions of interest
in the femoral head and proximal femur. We performed ﬁrst a logistic re-
gression analysis to test if Kelgren and Lawrence scores (KL) can predict
‘progression’ of OA, with the outcome ‘progression’ deﬁned as 20% joint
space narrowing or when patients received a total hip replacement within
the two years follow-up period. In addition we tested if (1) DXA parameters
contribute to the prediction of progression and (2) parameters that use
the difference between the affected and contralateral hip of the patient
contribute to the prediction. All the models were corrected for the variables
gender, age, weight and height. We used −2log likelihood test, R square
Nagelkerke and Areas Under the Receiver operator characterictic curves
(ROC) to compare the models.
Results: The model that included the DXA variables was signiﬁcantly
better in predicing hip OA progression than the model with KL score of
the affected side alone (p< 0.01). The addition of DXA differences within
hips slightly added to the prediction of progression (p< 0.05).
The difference in bone mineral density (BMD) and bone mineral content
(BMC) in the superior and medial part of the femoral head between the
